May 23, 2018 8:07 AM ET

Biotechnology

Company Overview of HemoShear Therapeutics, LLC

Key Executives for HemoShear Therapeutics, LLC

NameBoard RelationshipsTitleAge
James C. Powers 48 RelationshipsChairman and Chief Executive Officer65
Brett R. Blackman Ph.D.No RelationshipsCo-Founder and Chief Scientific Officer--
Brian R. Wamhoff Ph.D.8 RelationshipsCo-Founder, Vice President of Research & Development and Director--
Nicole E. Hastings Ph.D.No RelationshipsVice President of Operations--
John E. Reardon Ph.D.No RelationshipsHead of Research and Development--

HemoShear Therapeutics, LLC Board Members*

NameBoard RelationshipsPrimary CompanyAge
James C. Powers 48 RelationshipsHemoShear Therapeutics, LLC65
Brian R. Wamhoff Ph.D. 8 RelationshipsHemoShear Therapeutics, LLC--
W. McIlwaine Thompson Jr. 15 RelationshipsHemoShear Therapeutics, LLC57
Reginald F. Woods 9 RelationshipsDeHayes Consulting Group--
John L. Brooks III, CPA 53 RelationshipsPrism VentureWorks66
View All Board Members

HemoShear Therapeutics, LLC Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Executive Committee Reginald F. Woods9 Relationships1 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
453.2K
Bonus
278.9K
Total Short Term Compensation
392.0K
Total Value of Options
16.3M
Compensation as of Fiscal Year
HemoShear Therapeutics, LLC CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Race Oncology Limited Appoints Samar Al-Behaisi as Chief Medical Officer and Vice President of Medical Affairs, Effective 16 May 2018
May 14, 2018 11:37 PM ET
Unity Biotechnology, Inc. Appoints Camille Landis as Senior Vice President of Corporate Development
May 14, 2018 8:05 PM ET
bioAffinity Technologies, Inc. Welcomes Peter S. Knight to Board of Directors
May 14, 2018 2:00 PM ET
PolarityTE Appoints Caroline Garrett as Chief Veterinary Officer
May 14, 2018 12:30 PM ET
Synaffix BV Appoints John M. Lambert to its Scientific Advisory Board
May 14, 2018 12:05 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact HemoShear Therapeutics, LLC, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.